Stereotactic Radiotherapy Combined With Chemotherapy or Not for Treatment of Oligometastases in HNSCC
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the rate of living patients at 1 year with a quality of
life criteria (no decrease) and reduced toxicities. This criteria will be compared in both
groups., A cost effectiveness study is scheduled also.